\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ provided\\ initially\ \(0\)\
\-\ on\\ ct\\,\\ there\\ is\\ marked\\ and\\ diffuse\\ volume\\ loss\\,\\ ex\\ vacuole\\ dilatation\\ of\\ the\\ ventricles\\,\\ and\\ cystic\\ changes\\ of\\ the\\ basal\\ ganglia\\,\\ cerebellum\\ and\\ thalami\\.\ \(0\)\
\-\ follow\\-up\\ mr\\ again\\ reveals\\ diffuse\\ parenchymal\\ atrophy\\ with\\ cystic\\ degeneration\\ of\\ cerebellum\\,\\ cerebral\\ peduncles\\,\\ thalami\\ and\\ the\\ basal\\ ganglia\\.\\ on\\ spectroscopy\\,\\ there\\ is\\ a\\ significant\\ depression\\ of\\ the\\ naa\\ peak\\ with\\ a\\ resultant\\ increase\\ in\\ the\\ choline\\ peak\\.\\ lactate\\ is\\ also\\ present\\.\ \(0\)\
\-\ leigh\\'s\\ disease\\ \\(subacute\\ necrotizing\\ encephalopathy\\)\\.\ \(0\)\
\-\ profound\\ perinatal\\ asphyxia\ \(0\)\
\-\ mitochondrial\\ encephalopathy\\,\\ lactic\\ acidosis\\,\\ stroke\\-like\\ episodes\\ \\(melas\\)\ \(0\)\
\-\ glutaric\\ aciduria\\ type\\ i\ \(0\)\
\-\ wilson\\ disease\ \(1\)\
\-\ a\\ 2\\ month\\ old\\ male\\ with\\ mental\\ status\\ changes\\ for\\ evaluation\\ with\\ a\\ non\\-contrast\\ head\\ ct\\.\ \(0\)\
\-\ in\\ this\\ case\\,\\ there\\ is\\ extensive\\ white\\ matter\\ involvement\\ and\\ cerebral\\ atophy\\,\\ which\\ are\\ atypical\\ in\\ the\\ early\\ stages\\ of\\ leigh\\'s\\ syndrome\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leigh\\:\\ 0\\.2549781762079938\ \(0\)\
\-\ thalami\\:\\ 0\\.21550328657944162\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.203932955992343\ \(0\)\
\-\ peak\\:\\ 0\\.19837971784874467\ \(0\)\
\-\ ganglia\\:\\ 0\\.18195189727280744\ \(0\)\
\-\ cerebellum\\:\\ 0\\.17786700730665275\ \(0\)\
\-\ basal\\:\\ 0\\.16565741005870224\ \(0\)\
\-\ vacuole\\:\\ 0\\.1547995552513986\ \(0\)\
\-\ glutaric\\:\\ 0\\.1547995552513986\ \(0\)\
\-\ asphyxia\\:\\ 0\\.14791923919269565\ \(0\)\
\-\ melas\\:\\ 0\\.14791923919269565\ \(0\)\
\-\ aciduria\\:\\ 0\\.14791923919269565\ \(0\)\
\-\ atophy\\:\\ 0\\.14791923919269565\ \(0\)\
\-\ lactic\\:\\ 0\\.1361572612022762\ \(0\)\
\-\ cerebral\\:\\ 0\\.13412376946389554\ \(0\)\
\-\ naa\\:\\ 0\\.1335414864372808\ \(0\)\
\-\ perinatal\\:\\ 0\\.1335414864372808\ \(0\)\
\-\ choline\\:\\ 0\\.1312755992705597\ \(0\)\
\-\ mitochondrial\\:\\ 0\\.1312755992705597\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.12587177468404503\ \(0\)\
\-\ peduncles\\:\\ 0\\.12177950844686136\ \(0\)\
\-\ diffuse\\:\\ 0\\.12140746265608598\ \(0\)\
\-\ profound\\:\\ 0\\.11951362128014026\ \(0\)\
\-\ ex\\:\\ 0\\.11848488526637423\ \(0\)\
\-\ lactate\\:\\ 0\\.11751496715315378\ \(0\)\
\-\ changes\\:\\ 0\\.1170002007331986\ \(0\)\
\-\ cystic\\:\\ 0\\.11659514006381787\ \(0\)\
\-\ the\\:\\ 0\\.11588711294692224\ \(0\)\
\-\ there\\:\\ 0\\.11554573700802187\ \(0\)\
\-\ wilson\\:\\ 0\\.11335549707637672\ \(0\)\
\-\ acidosis\\:\\ 0\\.1100175304564419\ \(0\)\
\-\ is\\:\\ 0\\.10603411880212509\ \(0\)\
\-\ stages\\:\\ 0\\.10354612448097256\ \(0\)\
\-\ resultant\\:\\ 0\\.10159351908595726\ \(0\)\
\-\ necrotizing\\:\\ 0\\.10122858142255643\ \(0\)\
\-\ depression\\:\\ 0\\.10087132723101784\ \(0\)\
\-\ and\\:\\ 0\\.1000096261941591\ \(0\)\
\-\ of\\:\\ 0\\.09471377091202487\ \(0\)\
\-\ atrophy\\:\\ 0\\.0915784597622594\ \(0\)\
\-\ subacute\\:\\ 0\\.09058584071278668\ \(0\)\
\-\ degeneration\\:\\ 0\\.09001699591763132\ \(0\)\
\-\ episodes\\:\\ 0\\.08841664296617571\ \(0\)\
\-\ parenchymal\\:\\ 0\\.08695429817868991\ \(0\)\
\-\ again\\:\\ 0\\.08634273839516886\ \(0\)\
\-\ volume\\:\\ 0\\.08504235322002508\ \(0\)\
\-\ ventricles\\:\\ 0\\.08504235322002508\ \(0\)\
\-\ mental\\:\\ 0\\.08436077777402237\ \(0\)\
\-\ disease\\:\\ 0\\.08126392544573771\ \(0\)\
\-\ provided\\:\\ 0\\.07941244012855303\ \(0\)\
\-\ atypical\\:\\ 0\\.07941244012855303\ \(0\)\
\-\ dilatation\\:\\ 0\\.07901779565970969\ \(0\)\
\-\ increase\\:\\ 0\\.07770462544171754\ \(0\)\
\-\ initially\\:\\ 0\\.07590774476602434\ \(0\)\
\-\ with\\:\\ 0\\.07581628989406061\ \(0\)\
\-\ extensive\\:\\ 0\\.0745807604047494\ \(0\)\
\-\ ct\\:\\ 0\\.07370309125949676\ \(0\)\
\-\ matter\\:\\ 0\\.0737028604714175\ \(0\)\
\-\ reveals\\:\\ 0\\.07363171174111291\ \(0\)\
\-\ marked\\:\\ 0\\.07321097248534182\ \(0\)\
\-\ in\\:\\ 0\\.07223989350939432\ \(0\)\
\-\ involvement\\:\\ 0\\.07005954802232839\ \(0\)\
\-\ early\\:\\ 0\\.06977434891705328\ \(0\)\
\-\ status\\:\\ 0\\.0675509372351331\ \(0\)\
\-\ type\\:\\ 0\\.06493516247013771\ \(0\)\
\-\ white\\:\\ 0\\.06386395097157076\ \(0\)\
\-\ mr\\:\\ 0\\.06263210344338706\ \(0\)\
\-\ evaluation\\:\\ 0\\.059032271247767124\ \(0\)\
\-\ loss\\:\\ 0\\.058972310240791144\ \(0\)\
\-\ month\\:\\ 0\\.05888276413685378\ \(0\)\
\-\ on\\:\\ 0\\.058468741009054456\ \(0\)\
\-\ syndrome\\:\\ 0\\.05835518960278223\ \(0\)\
\-\ head\\:\\ 0\\.057731886072623355\ \(0\)\
\-\ significant\\:\\ 0\\.05588848414771412\ \(0\)\
\-\ none\\:\\ 0\\.05289897551087497\ \(0\)\
\-\ present\\:\\ 0\\.04966971008044508\ \(0\)\
\-\ case\\:\\ 0\\.0486297851904759\ \(0\)\
\-\ also\\:\\ 0\\.04553055804319525\ \(0\)\
\-\ which\\:\\ 0\\.04401458158452956\ \(0\)\
\-\ male\\:\\ 0\\.043097770143528634\ \(0\)\
\-\ are\\:\\ 0\\.03673007805798415\ \(0\)\
\-\ this\\:\\ 0\\.03326120944946013\ \(0\)\
\-\ for\\:\\ 0\\.029338442878083654\ \(0\)\
\-\ old\\:\\ 0\\.028648033386842627\ \(0\)\
